Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-26 @ 5:01 AM
Study NCT ID:
NCT00377559
Status:
COMPLETED
Last Update Posted:
2015-10-06
First Post:
2006-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer
Sponsor:
Catharina Ziekenhuis Eindhoven
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-15
First Submit QC Date:
None
Study First Post Date:
2006-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-05
Last Update Post Date:
2015-10-06
Last Update Post Date Type:
ESTIMATED